Health Catalyst Inc reports results for the quarter ended in December - Earnings Summary

Health Catalyst

28/02/2023 22:40

* Health Catalyst Inc  HCAT.OQ  reported a quarterly
adjusted loss
of 5 cents​​ per share for the quarter ended in December. The
mean expectation of thirteen analysts for the quarter was for a
loss of 11 cents per share.
    * Revenue rose 6.9% to $69.16 million from a year ago;
analysts
expected $68.26 million. 
    * Health Catalyst Inc's reported EPS for the quarter was a
loss
of 66 cents​.
    * The mean earnings estimate of analysts had risen by
about 3.1%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Health Catalyst Inc shares had risen by 25.6% this
quarter.
    * The company reported a quarterly loss of $35.78 million.
    * Wall Street's median 12-month price target for Health
Catalyst
Inc is $15.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 7
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data February
28 at 10:40 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.11          -0.05          Beat
 Sep. 30 2022      -0.19          -0.13          Beat
 Jun. 30 2022      -0.10          -0.03          Beat
 Mar. 31 2022      -0.11          -0.06          Beat